Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Small interfering RNA
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
=== Viral-mediated delivery === The gene silencing effects of transfected designed siRNA are generally transient, but this difficulty can be overcome through an RNAi approach. Delivering this siRNA from DNA templates can be done through several recombinant viral vectors based on retrovirus, adeno-associated virus, [[adenovirus]], and [[lentivirus]].<ref>{{cite book | vauthors = Talwar GP, Hasnain S, Sarin SK | date = January 2016 | title = Textbook of Biochemistry, Biotechnology, Allied and Molecular Medicine | edition = 4th | publisher = PHI Learning Private Limited | page = 873 | isbn = 978-81-203-5125-7 }}</ref> The latter is the most efficient virus that stably delivers siRNA to target cells as it can transduce nondividing cells as well as directly target the nucleus.<ref name=pmid16397511>{{cite journal | vauthors = Morris KV, Rossi JJ | title = Lentiviral-mediated delivery of siRNAs for antiviral therapy | journal = Gene Therapy | volume = 13 | issue = 6 | pages = 553β8 | date = March 2006 | pmid = 16397511 | pmc = 7091755 | doi = 10.1038/sj.gt.3302688 }}</ref> These specific viral vectors have been synthesized to effectively facilitate siRNA that is not viable for transfection into cells. Another aspect is that in some cases synthetic viral vectors can integrate siRNA into the cell genome which allows for stable expression of siRNA and long-term gene knockdown. This technique is advantageous because it is in vivo and effective for difficult to transfect cell. However problems arise because it can trigger antiviral responses in some cell types leading to mutagenic and immunogenic effects. This method has potential use in gene silencing of the central nervous system for the treatment of [[Huntington's disease]].<ref>{{cite book | vauthors = Cambon K, DΓ©glon N | title = Trinucleotide Repeat Protocols | chapter = Lentiviral-Mediated Gene Transfer of siRNAs for the Treatment of Huntington's Disease | series = Methods in Molecular Biology | volume = 1010 | pages = 95β109 | year = 2013 | pmid = 23754221 | doi = 10.1007/978-1-62703-411-1_7 | isbn = 978-1-62703-410-4 }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)